NexOptic Technology Corp. signs MOU with IntroMedic

CIOTechOutlook Team | Wednesday, 15 March 2023, 03:06 IST

  • No Image
NexOptic jointly announce that they have entered a non-binding memorandum of agreement ("MOU"). The goal of IntroMedic, a pioneer in medical imaging analysis and global capsule endoscopy technology, is to continuously raise the bar for its unique imaging and analysis products. The IntroMedic website has more information: IntroMedic
 
"In our ongoing efforts to always put patients and medical experts first, I am very encouraged by the measurable improvements to image quality that NexOptic has been able to demonstrate to us." Said Mr. Andrew Shim, President of IntroMedic.
 
A small wireless camera is used during a technique called a capsule endoscopy to take images of the digestive system. The capsule endoscopic camera from IntroMedic is swallowed and is the size of a vitamin. A recorder attached to a belt around the patient's waist receives millions of photographs taken by the camera as it passes through the digestive tract. Capsule endoscopy is gaining popularity since it is much less invasive and uncomfortable for the patient than more conventional endoscopic procedures.
 
Particularly, IntroMedic's MiroCam® capsule endoscope offers a greater field of vision of 170 degrees which permits a more thorough examination of portions of the digestive system, additionally its 12-hour operative time mitigates numerous concerns common in rival solutions. In comparison to its rivals, MiroCam offers a number of technological benefits thanks to IntroMedic's unique Human Body Communication (HBC), Augmented Live-body Image Colour-Spectrum Enhancement (ALICE), and Medical Image Processing (MIP) technologies.  
 
Late in 2021, NexOptic and IntroMedic started talking, and since then, there have been numerous rounds of evaluation and development.      
 
Paul McKenzie, CEO of NexOptic stated, "It's been an encouraging relationship with IntroMedic and we are excited for the possibility of playing a role in more technologies that further benefit human health and lifestyle."
 
The announcement shows both businesses' enthusiasm for implementing a prospective per capsule, licenced model. If successful, this would be the second commercial deployment of ALIIS into medical imaging equipment, a market that NexOptic is well-positioned to enter quickly because it usually requires small lens factors for demanding use-cases. 
🍪 Do you like cookies?

We use cookies to ensure you get the best experience on our website. Read more...